Skip to main content

Applied DNA Sciences, Inc. (APDN)

NASDAQ: APDN · IEX Real-Time Price · USD
5.40 -0.15 (-2.70%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap40.43M
Revenue (ttm)6.30M
Net Income (ttm)-13.90M
Shares Out7.49M
EPS (ttm)-2.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume56,729
Open5.50
Previous Close5.55
Day's Range5.35 - 5.55
52-Week Range4.95 - 13.64
Beta1.01
AnalystsBuy
Price Target17.67 (+227.2%)
Est. Earnings DateDec 16, 2021

About APDN

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fort...

IndustryElectronic Equipment, Instruments & Components
Founded1983
CEOJames Hayward
Employees59
Stock ExchangeNASDAQ
Ticker SymbolAPDN
Full Company Profile

Financial Performance

In 2020, APDN's revenue was $1.93 million, a decrease of -64.16% compared to the previous year's $5.39 million. Losses were -$13.03 million, 51.1% more than in 2019.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for APDN stock is "Buy." The 12-month stock price forecast is 17.67, which is an increase of 227.22% from the latest price.

Price Target
$17.67
(227.22% upside)
Analyst Consensus: Buy

News

Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging,...

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #cannabis--Companies Advances Cannabis Partnership.

1 week ago - Business Wire

Flora Growth Launches Cannabis Product Validation And Authentication Platform With TruTrace And Applied DNA Sciences

Flora Growth Corp. (NASDAQ:FLGC) announced Thursday it has signed agreements with TruTrace Technologies, Inc. (CSE:TTT) (OTCQB:TTTSF) and Applied DNA Sciences, Inc. (NASDAQ:APDN) to launch a complete an...

Other symbols:FLGC
2 weeks ago - Benzinga

Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secur...

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #cannabis--Applied DNA Enters Into Master Services Agreement with Flora Growth for Cannabis Validation and Secures First Statement of Work.

2 weeks ago - Business Wire

Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19Testing--Applied DNA CEO to present at upcoming H.C. Wainwright 23rd Annual Global Investment Conference (virtual).

2 weeks ago - Business Wire

Applied DNA Stock Jumps On New COVID-19 Testing Contract

Applied DNA Sciences Inc's (NASDAQ:APDN) subsidiary Applied DNA Clinical Labs has been awarded a testing contract by Suffolk County Community College. Also Read:   Applied DNA Receives COVID-19 testing ...

3 weeks ago - Benzinga

Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19Testing--Applied DNA to monitor for the prevalence of COVID-19 among Suffolk County Community College's unvaccinated staff and faculty.

3 weeks ago - Business Wire

Applied DNA Sciences (APDN) Reports Q3 Loss, Lags Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -91.67% and -50.51%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Recap: Applied DNA Sciences Q3 Earnings

Shares of Applied DNA Sciences (NASDAQ:APDN) fell 7.8% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 36.11% year over year to ($0.46), which mi...

1 month ago - Benzinga

Applied DNA Announces Third Quarter Fiscal 2021

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVIDDiagnostics--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic...

1 month ago - Business Wire

Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12...

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVIDDiagnostics--Applied DNA Sciences Schedules FQ3'21 Investor Call and Webcast.

1 month ago - Business Wire

Why Is Applied DNA Stock Soaring Higher Today?

Applied DNA Sciences Inc's (NASDAQ:APDN) subsidiary Applied DNA Clinical Labs LLC has received a COVID-19 testing contract by the City University of New York (CUNY) to facilitate the University's reopen...

1 month ago - Benzinga

Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Secures COVID-19 Testing Award From The City University of New York with a Maximum Value of $35.0 Million

1 month ago - Business Wire

New Strong Sell Stocks for June 29th

ITRG, TARA, QTNT, VNCE and APDN have been added to the Zacks Rank #5 (Strong Sell) List on June 29, 2021.

Other symbols:ITRGQTNTTARAVNCE
2 months ago - Zacks Investment Research

Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads

STONY BROOK, N.Y. & CHARLOTTE, N.C.--(BUSINESS WIRE)---- $APDN #AE--Applied DNA and A&E come together to bring an innovative and economical solution to brands to authenticate and validate their products.

3 months ago - Business Wire

Applied DNA's Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies Against Three Variants

Applied DNA Sciences Inc (NASDAQ: APDN) and its program development partner, Evvivax S.R.L., have announced results from an in vitro neutralization study of sera evaluating the company's COVID-19 vaccin...

3 months ago - Benzinga

Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Aga...

STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)---- $APDN #COVIDDiagnostics--Applied DNA veterinary COVID-19 vaccine induces NAbs against B.1.1.7, P1, and B.1.526 variants; Set launch of mink challenge trial ...

3 months ago - Business Wire

Breaking Down a Busy Week of Weed Stocks

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...

3 months ago - Schaeffers Research

Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--The acquisition of safeCircle's newest client reflects the service's focus on profitable niche markets and the re-opening of venues for new sales.

3 months ago - Business Wire

Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Ra...

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Completes Technical Validation of SARS-CoV-2 Mutation Detection Panel; Developing Mutation that Characterizes Indian Variant.

3 months ago - Business Wire

Here Are the Cannabis Stocks That Caught Fire This Week

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...

4 months ago - Schaeffers Research

Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 ...

STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), today clarifies the scope of its newly authorized asymptomatic serial screening indication f...

4 months ago - Business Wire

Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -83.33% and 1.99%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced con...

4 months ago - Business Wire

FDA Grants EUA to Applied DNA LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Linea™ COVID-19 Assay Kit EUA expanded to include asymptomatic serial screening as an expansion of intended use.

4 months ago - Business Wire

Applied DNA Receives CLIA Certification, Enabling High Throughput Diagnostic COVID-19 Testing

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, toda...

4 months ago - Business Wire